TerminatedPHASE1, PHASE2NCT03576885

Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AdventHealth
Principal Investigator
Hussnain Mirza, MD, MD
AdventHealth
Intervention
inhaled nitric oxide(drug)
Enrollment
32 enrolled
Eligibility
All sexes
Timeline
20192023

Study locations (1)

Collaborators

Mallinckrodt · Thrasher Research Fund

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03576885 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia

← Back to all trials